Extensively drug-resistant tuberculosis in a young child after travel to India

The Lancet Infectious Diseases

Volumn 15, Issue 12, 2015, Pages 1485-1491

  Salazar Austin, Nicole ^a   Ordonez, Alvaro A ^a   Hsu, Alice Jenh ^a   Benson, Jane E ^a   Mahesh, Mahadevappa ^a   Menachery, Elizabeth ^b   Razeq, Jafar H ^c   Salfinger, Max ^d   Starke, Jeffrey R ^e   Milstone, Aaron M ^a   Parrish, Nicole ^a   Nuermberger, Eric L ^a   Jain, Sanjay K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Howard County Health Department   (United States)

^c MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d DEPARTMENT OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; C REACTIVE PROTEIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; LEVOTHYROXINE; LINEZOLID; PYRAZINAMIDE; PYRIDOXINE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

BACTERIUM ISOLATE; BLOOD PRESSURE; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPOTHYROIDISM; INDIA; LUNG HILUS; LYMPHADENOPATHY; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; OXYGEN SATURATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; REVIEW; SKIN DISCOLORATION; SUSCEPTIBLE POPULATION; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT DURATION; WHEEZING; DIAGNOSTIC IMAGING; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; PNEUMONIA, BACTERIAL; RADIOGRAPHY; TRAVEL; TUBERCULOSIS, PULMONARY; UNITED STATES;

ANTITUBERCULAR AGENTS; CHILD, PRESCHOOL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; INDIA; MYCOBACTERIUM TUBERCULOSIS; PNEUMONIA, BACTERIAL; RADIOGRAPHY; TRAVEL; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 84960413216     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00356-4     Document Type: Review

References (72)

1. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006, 368:1575-1580.
2. Global tuberculosis report 2015 WHO, (accessed Oct 28, 2015). http://www.who.int/tb/publications/global_report/en/.
3. Michael JS, John TJ Extensively drug-resistant tuberculosis in India: a review. Indian J Med Res 2012, 136:599-604.
4. Schlagenhauf P, Weld L, Goorhuis A, et al. Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation. Lancet Infect Dis 2015, 15:55-64.
5. Marienau KJ, Burgess GW, Cramer E, et al. Tuberculosis investigations associated with air travel: U. S. Centers for Disease Control and Prevention, January 2007-June 2008. Travel Med Infect Dis 2010, 8:104-112.
6. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Beyers N The burden of childhood tuberculosis and the accuracy of community-based surveillance data. Int J Tuberc Lung Dis 2006, 10:259-263.
7. Swaminathan S, Rekha B Pediatric tuberculosis: global overview and challenges. Clin Infect Dis 2010, 50(suppl 3):S184-S194.
8. Perez-Velez CM, Marais BJ Tuberculosis in children. N Engl J Med 2012, 367:348-361.
9. Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children. Int J Tuberc Lung Dis 2012, 16:1588-1593.
10. Katragkou A, Antachopoulos C, Hatziagorou E, Sdougka M, Roilides E, Tsanakas J Drug-resistant tuberculosis in two children in Greece: report of the first extensively drug-resistant case. Eur J Pediatr 2013, 172:563-567.
11. Alsleben N, Garcia-Prats AJ, Hesseling AC, Willemse M, Donald PR, Schaaf HS Successful treatment of a child with extensively drug-resistant tuberculous meningitis. J Ped Infect Dis 2015, 4:e41-e44.
12. Oberhelman RA, Soto-Castellares G, Gilman RH, et al. Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis 2010, 10:612-620.
13. Stockdale AJ, Duke T, Graham S, Kelly J Evidence behind the WHO guidelines: hospital care for children: what is the diagnostic accuracy of gastric aspiration for the diagnosis of tuberculosis in children?. J Trop Pediatr 2010, 56:291-298.
14. Nicol MP, Workman L, Isaacs W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011, 11:819-824.
15. Jain SK, Ordonez A, Kinikar A, et al. Pediatric tuberculosis in young children in India: a prospective study. Biomed Res Int 2013, 2013:783698.
16. Mukherjee A, Singh S, Lodha R, et al. Ambulatory gastric lavages provide better yields of Mycobacterium tuberculosis than induced sputum in children with intrathoracic tuberculosis. Pediatr Infect Dis J 2013, 32:1313-1317.
17. Cloud JL, Neal H, Rosenberry R, et al. Identification of Mycobacterium spp. by using a commercial 16S ribosomal DNA sequencing kit and additional sequencing libraries. J Clin Microbiol 2002, 40:400-406.
18. Ansart S, Perez L, Vergely O, Danis M, Bricaire F, Caumes E Illnesses in travelers returning from the tropics: a prospective study of 622 patients. J Travel Med 2005, 12:312-318.
19. Monge-Maillo B, Norman FF, Perez-Molina JA, Navarro M, Diaz-Menendez M, Lopez-Velez R Travelers visiting friends and relatives (VFR) and imported infectious disease: travelers, immigrants or both? A comparative analysis. Travel Med Infect Dis 2014, 12:88-94.
20. Hunziker T, Berger C, Staubli G, et al. Profile of travel-associated illness in children, Zurich, Switzerland. J Travel Med 2012, 19:158-162.
21. Driver CR, Valway SE, Morgan WM, Onorato IM, Castro KG Transmission of Mycobacterium tuberculosis associated with air travel. JAMA 1994, 272:1031-1035.
22. Byrne N Low prevalence of TB on long-haul aircraft. Travel Med Infect Dis 2007, 5:18-23.
23. Cobelens FG, van Deutekom H, Draayer-Jansen IW, et al. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 2000, 356:461-465.
24. Cobelens FG, van Deutekom H, Draayer-Jansen IW, et al. Association of tuberculin sensitivity in Dutch adults with history of travel to areas of with a high incidence of tuberculosis. Clin Infect Dis 2001, 33:300-304.
25. Kik SV, Mensen M, Beltman M, et al. Risk of travelling to the country of origin for tuberculosis among immigrants living in a low-incidence country. Int J Tuberc Lung Dis 2011, 15:38-43.
26. Mancuso JD, Tobler SK, Eick AA, Keep LW Active tuberculosis and recent overseas deployment in the U.S. military. Am J Prev Med 2010, 39:157-163.
27. Slopen ME, Laraque F, Piatek AS, Ahuja SD Missed opportunities for tuberculosis prevention in New York City, 2003. J Public Health Manag Pract 2011, 17:421-426.
28. Hendel-Paterson B, Swanson SJ Pediatric travelers visiting friends and relatives (VFR) abroad: illnesses, barriers and pre-travel recommendations. Travel Med Infect Dis 2011, 9:192-203.
29. Lobato MN, Hopewell PC Mycobacterium tuberculosis infection after travel to or contact with visitors from countries with a high prevalence of tuberculosis. Am J Respir Crit Care Med 1998, 158:1871-1875.
30. Rieder HL Risk of travel-associated tuberculosis. Clin Infect Dis 2001, 33:1393-1396.
31. Ritz N, Connell TG, Curtis N To BCG or not to BCG? Preventing travel-associated tuberculosis in children. Vaccine 2008, 26:5905-5910.
32. Bates M, O'Grady J, Maeurer M, et al. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Lancet Infect Dis 2013, 13:36-42.
33. Zar HJ, Hanslo D, Apolles P, Swingler G, Hussey G Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005, 365:130-134.
34. Moore HA, Apolles P, de Villiers PJ, Zar HJ Sputum induction for microbiological diagnosis of childhood pulmonary tuberculosis in a community setting. Int J Tuberc Lung Dis 2011, 15:1185-1190. i.
35. Planting NS, Visser GL, Nicol MP, Workman L, Isaacs W, Zar HJ Safety and efficacy of induced sputum in young children hospitalised with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis 2014, 18:8-12.
36. Zar HJ, Workman L, Isaacs W, et al. Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. Clin Infect Dis 2012, 55:1088-1095.
37. Zar HJ, Workman L, Isaacs W, Dheda K, Zemanay W, Nicol MP Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study. Lancet Glob Health 2013, 1:e97-104.
38. Hatherill M, Hawkridge T, Zar HJ, et al. Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis?. Arch Dis Child 2009, 94:195-201.
39. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363:1005-1015.
40. Nicol MP, Spiers K, Workman L, et al. Xpert MTB/RIF testing of stool samples for the diagnosis of pulmonary tuberculosis in children. Clin Infect Dis 2013, 57:e18-e21.
41. Al-Aghbari N, Al-Sonboli N, Yassin MA, et al. Multiple sampling in one day to optimize smear microscopy in children with tuberculosis in Yemen. PLoS One 2009, 4:e5140.
42. Nicol MP, Allen V, Workman L, et al. Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study. Lancet Glob Health 2014, 2:e278-e284.
43. Kroidl I, Clowes P, Reither K, et al. Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania. Eur Respir J 2015, 46:761-770.
44. Jenkins HE, Tolman AW, Yuen CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014, 383:1572-1579.
45. Sanchez-Padilla E, Merker M, Beckert P, et al. Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med 2015, 372:1181-1182.
46. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis WHO, (accessed Sept 5, 2015). http://apps.who.int/iris/bitstream/10665/130918/1/9789241548809_eng.pdf?ua=1&ua=1.
47. Seddon J, Furin JJ, Gale M, et al. Caring for children with drug-resistant tuberculosis practice-based recommendations. Am J Respir Crit Care Med 2012, 186:953-964.
48. Garcia-Prats AJ, Rose PC, Hesseling AC, Schaaf HS Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations. Tuberculosis 2014, 94:93-104.
49. Pyle MM Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation. Ann N Y Acad Sci 1966, 135:835-845.
50. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948, 2:769-782. Streptomycin in Tuberculosis Trials Committee.
51. Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F, Rigouts L High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother 2009, 53:5064-5068.
52. Fox W, Sutherland I A five-year assessment of patients in a controlled trial of streptomycin, para-aminosalicylic acid, and streptomycin plus para-aminosalicylic acid, in pulmonary tuberculosis. Q J Med 1956, 25:221-243.
53. Donald PR, Diacon AH Para-aminosalicylic acid: the return of an old friend. Lancet Infect Dis 2015, 15:1091-1099.
54. Lee M, Lee J, Carroll MW, et al. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med 2012, 367:1508-1518.
55. Dey T, Brigden G, Cox H, Shubber Z, Cooke G, Ford N Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2013, 68:284-293.
56. Thee S, Seifart HI, Rosenkranz B, et al. Pharmacokinetics of ethionamide in children. Antimicrob Agents Chemother 2011, 55:4594-4600.
57. Peloquin CA, Durbin D, Childs J, Sterling TR, Weiner M Stability of antituberculosis drugs mixed in food. Clin Infect Dis 2007, 45:521.
58. 18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. Antimicrob Agents Chemother 2009, 53:4879-4884.
59. Ordonez AA, Pokkali S, DeMarco VP, et al. Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in mice. Antimicrob Agents Chemother 2015, 59:642-649.
60. Luna B, Kubler A, Larsson C, et al. In vivo prediction of tuberculosis-associated cavity formation in rabbits. J Infect Dis 2015, 211:481-485.
61. 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis. J Nucl Med 2011, 52:880-885.
62. Heysell SK, Thomas TA, Sifri CD, Rehm PK, Houpt ER 18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series. BMC Pulm Med 2013, 13:14.
63. Chen RY, Dodd LE, Lee M, et al. PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis. Sci Transl Med 2014, 6:265ra166.
64. Tangg SJ, Zhang Q, Zheng LH, et al. Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis. Jpn J Infect Dis 2011, 64:509-512.
65. Yanardag H, Tetikkurt C, Tetikkurt S, Demirci S, Karayel T Computed tomography and bronchoscopy in endobronchial tuberculosis. Can Respir J 2003, 10:445-448.
66. Kim WS, Choi JI, Cheon JE, Kim IO, Yeon KM, Lee HJ Pulmonary tuberculosis in infants: radiographic and CT findings. AJR Am J Roentgenol 2006, 187:1024-1033.
67. Backus KM, Boshoff HI, Barry CS, et al. Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis. Nat Chem Biol 2011, 7:228-235.
68. 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med 2014, 6:259ra146.
69. Mahesh M Advances in CT technology and application to pediatric imaging. Pediatr Radiol 2011, 41(suppl 2):493-497.
70. The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local Challenges and Solutions: Summary of a Joint Workshop (accessed Sept 5, 2015). http://www.ncbi.nlm.nih.gov/books/NBK55582/.
71. Cruz AT, Medina D, Whaley EM, Ware KM, Koy TH, Starke JR Tuberculosis among families of children with suspected tuberculosis and employees at a children's hospital. Infect Control Hosp Epidemiol 2011, 32:188-190.
72. Dharmadhikari AS, Mphahlele M, Venter K, et al. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2014, 18:1019-1025.